Variable types of investigations exist regarding counterfeit drug detection, disruption, and regulation. Counterfeit drugs are spurious drugs, falsely labelled, falsified, substandard, unregistered/unlicensed, and infringe trademarks. Counterfeit drugs can mimic both legitimate and illegitimate drugs and are often distributed in virtual environments, such as illicit online pharmacies, the surface web, and the dark web. Counterfeit drug operators and operations are the typically corrupt and/or criminal individuals, groups, and techniques by which counterfeit drugs are produced and distributed. The manufacture and distribution of counterfeit drugs are ever-changing, which results in the need for investigative techniques that are equally adaptable and collaborative. Counterfeit drug investigations can be defined according to four categories: medical investigations in hospitals and through autopsies, chemical and non-chemical drug investigations in forensic toxicology laboratories, various track-and-trace technologies used in pharmaceutical industry investigations, and national and global coordinated investigations. Due to the diverse counterfeit drug investigations present, the logic and practice of abduction are highlighted as a primary part of the investigative element to counter ongoing efforts by offenders to evade detection. Abductive rationalities are prioritized in that they are contrary to an increasing reliance on technoscientific modes of data production alone. Rather, abductive reasoning plays a central role in counterfeit drug investigations at the levels of instigating and directing investigations, as well as interpreting and responding to evidential findings.
